Turkish Pharmaceutical Granted 3-Month Temporary Moratorium in Bankruptcy Proceedings; Shares Moved to Close Monitoring Market

In the bankruptcy proceedings filed against Türk İlaç ve Serum Sanayi A.Ş., the court has granted the company a temporary moratorium for a period of three months. The decision is intended to protect creditors while the company restructures its financial position. Under the bankruptcy process, Türk İlaç’s shares will be listed on the Close Monitoring Market (Yakın İzleme Pazarı) of Borsa İstanbul. This market is designed for companies whose financial structures are weakening or whose operations face continuity risks. The temporary moratorium provides the company with an opportunity to restructure its debts and avoid liquidation. During this period, the company’s financial statements and operational performance will be closely monitored. Investors should be aware that following the transfer of Türk İlaç shares to the Close Monitoring Market, price volatility may occur. A successful conclusion of the bankruptcy proceedings is critical for the company’s future. This is not investment advice.